cytidine has been researched along with stilbenes in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
McCloskey, JA; Schram, KH; Scribner, JD; Scribner, NK; Smith, DL | 1 |
Bernhaus, A; Erker, T; Fritzer-Szekeres, M; Graser, G; Grusch, M; Handler, N; Horvath, Z; Jaeger, W; Jaschke, M; Krupitza, G; Lackner, A; Madlener, S; Ozsvar-Kozma, M; Saiko, P; Szekeres, T | 1 |
Fritzer-Szekeres, M; Giessrigl, B; Golakoti, T; Graser, G; Grusch, M; Jaeger, W; Krupitza, G; Lackner, A; Saiko, P; Schuster, H; Somepalli, V; Steinmann, MT; Szekeres, T | 1 |
3 other study(ies) available for cytidine and stilbenes
Article | Year |
---|---|
Reactions of the carcinogen N-acetoxy-4-acetamidostilbene with nucleosides.
Topics: Adenosine; Carcinogens; Chemical Phenomena; Chemistry; Cytidine; Guanosine; Hydrolysis; Mass Spectrometry; Ribonucleosides; Spectrophotometry, Ultraviolet; Stilbenes | 1979 |
N-hydroxy-N'-(3,4,5-trimethoxyphenyl)-3,4,5-trimethoxy-benzamidine, a novel resveratrol analog, inhibits ribonucleotide reductase in HL-60 human promyelocytic leukemia cells: synergistic antitumor activity with arabinofuranosylcytosine.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cytarabine; Cytidine; Drug Synergism; Enzyme Inhibitors; HL-60 Cells; Humans; Resveratrol; Ribonucleotide Reductases; Stilbenes | 2007 |
Digalloylresveratrol, a novel resveratrol analog inhibits the growth of human pancreatic cancer cells.
Topics: Antineoplastic Agents; Biphenyl Compounds; Cell Cycle; Cell Line, Tumor; Cytidine; DNA; Free Radical Scavengers; Gallic Acid; Humans; Mitogen-Activated Protein Kinases; Pancreatic Neoplasms; Picrates; Proto-Oncogene Mas; Ribonucleotide Reductases; Stilbenes | 2013 |